Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report.
Inappropriate sinus tachycardia is a disease which is relatively rarely found and sometimes difficult to treat. Up to now it has been mostly treated with a beta-blocker or verapamil. If this did not work sinus node modulation was considered. Since the relatively new selective IF-stream blocker ivabradine has been approved for the therapy of chronic stable angina pectoris, a new therapeutic option is available. As ivabradine is well tolerated and only few side effects are known, it may become a new therapeutic step between medication and the invasive sinus node modulation. We report the case of a young female patient with inappropriate sinus tachycardia where a sustained therapeutic success was achieved with ivabradine medication as an alternative therapeutic trial after various ineffective medications.
Schulze
Volker
V
Klinik für Kardiologie, Pneumologie und Angiologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland. volker.schulze@med.uni-duesseldorf.de
Steiner
Stefan
S
Hennersdorf
Marcus
M
Strauer
Bodo-Eckehard
BE
D000328:Adult; D001552:Benzazepines / Q000627:therapeutic use*; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006801:Humans; D000077550:Ivabradine; D013616:Tachycardia, Sinus / Q000188:drug therapy* / Q000503:physiopathology
D001552:Benzazepines; D054815:Cyclic Nucleotide-Gated Cation Channels; D000077550:Ivabradine